CHIKV an infection leads to MCP-induced cellular infiltration in the inflamed joints, and bone loss could be ameliorated by treatment method having an MCP-inhibiting drug, bindarit. Taken together, our data expose a Formerly undescribed part for MCPs in CHIKV-induced bone loss: amongst recruiting monocytes/OC precursors to joint sites and thus https://englandb322nyj4.blog-mall.com/profile